This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (8) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Nguyen, T Q Articles by Sontheimer, R D Search for Related Content PubMed PubMed Citation Articles by Nguyen, T Q Articles by Sontheimer, R D Social Bookmarking                   What's this?

4-Aminoquinoline antimalarials enhance UV-B induced c–jun transcriptional activation

Department of Dermatology, the University of Texas Southwestern Medical Center, Dallas, Texas 75235, USA

J D Capra

Department of Microbiology, the University of Texas Southwestern Medical Center, Dallas, Texas 75235, USA; Department of Internal Medicine, the University of Texas Southwestern Medical Center, Dallas, Texas 75235, USA

R D Sontheimer

Department of Dermatology, the University of Texas Southwestern Medical Center, Dallas, Texas 75235, USA; Department of Internal Medicine, the University of Texas Southwestern Medical Center, Dallas, Texas 75235, USA

Previous work has documented that the earliest observable response in mammalian cells following ultraviolet (UV) irradiation is the activation of plasma membrane-associated Src tyrosine kinases. These molecules then trigger a signalling cascade that results in activation of the transcription factor AP-1 which subsequently transactivates the early immediate genes including c–jun. This pathway has been postulated to play a protective role against UV damage. As aminoquinoline antimalarials such as chloroquine are known to downregulate several photoinduced cutaneous disorders including LE-specific skin disease, we asked whether chloroquine might be capable of modulating this early limb of the UV light response. A431 cells (a human epidermal keratinocyte cell line) that had been transfected with a c–jun luciferase reporter gene construct were then treated with physiologically relevant concentrations of chloroquine followed by exposure to 0—125 J/m² of UV-B from a bank of unfiltered FS20 lamps. Chloroquine pretreatment resulted in a dose–dependent increase in luciferase activity in permanently transfected A431 cells (luciferase activity was increased by 45% at 2.5 x 10^-5 M chloroquine and 125 J/m² of UV-B).

Hydroxychloroquine pretreatment also resulted in an increase in luciferase activity. Primaquine, an 8-aminoquinoline, did not influence the UV-B induced c-jun activity. Furthermore, chloroquine did not have a similar impact on HSP-70 gene activity during heat shock. These studies suggest that the beneficial effect of the 4-aminoquinoline antimalarials in various photodermatoses including cutaneous LE might result in part from the capacity of these drugs to enhance the protective early limb of the UV response.

Key Words: luciferase • keratinocyte • reporter gene

Lupus, Vol. 7, No. 3, 148-153 (1998)
DOI: 10.1191/096120398678919912


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E Toubi, A Kessel, I Rosner, M Rozenbaum, M Lorber, D Paran, E Sabo, and T D Golan Quinacrine added to ongoing therapeutic regimens attenuates anticardiolipin antibody production in SLE Lupus, April 1, 2003; 12(4): 297 - 301. [Abstract] [PDF]

				D D'Cruz Antimalarial therapy: a panacea for mild lupus? Lupus, March 1, 2001; 10(3): 148 - 151. [Abstract] [PDF]

				E Toubi, I Rosner, M Rozenbaum, A Kessel, and T D Golan The benefit of combining hydroxychloroquine with quinacrine in the treatment of SLE patients Lupus, February 1, 2000; 9(2): 92 - 95. [Abstract] [PDF]